These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 3348703)

  • 1. Effect of electrophysiological testing on ejection fraction during cardioverter/defibrillator implantation.
    Antunes ML; Spotnitz HM; Livelli FD; Steinberg JS; Bigger JT
    Ann Thorac Surg; 1988 Mar; 45(3):315-8. PubMed ID: 3348703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical evaluation of the internal automatic cardioverter-defibrillator in survivors of sudden cardiac death.
    Reid PR; Mirowski M; Mower MM; Platia EV; Griffith LS; Watkins L; Bach SM; Imran M; Thomas A
    Am J Cardiol; 1983 Jun; 51(10):1608-13. PubMed ID: 6858865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regional Longitudinal Deformation Improves Prediction of Ventricular Tachyarrhythmias in Patients With Heart Failure With Reduced Ejection Fraction: A MADIT-CRT Substudy (Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy).
    Biering-Sørensen T; Knappe D; Pouleur AC; Claggett B; Wang PJ; Moss AJ; Solomon SD; Kutyifa V
    Circ Cardiovasc Imaging; 2017 Jan; 10(1):. PubMed ID: 28003221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Initial clinical experience with endocardial defibrillation using an implantable cardioverter/defibrillator with a triple-electrode system.
    Saksena S; Tullo NG; Krol RB; Mauro AM
    Arch Intern Med; 1989 Oct; 149(10):2333-9. PubMed ID: 2802898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of automatic multimodal device therapy for ventricular tachyarrhythmias as delivered by a new implantable pacing cardioverter-defibrillator. Results of a European multicenter study of 102 implants.
    Fromer M; Brachmann J; Block M; Siebels J; Hoffmann E; Almendral J; Ohm OJ; den Dulk K; Coumel P; Camm AJ
    Circulation; 1992 Aug; 86(2):363-74. PubMed ID: 1638705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Operative mortality with implantation of the automatic cardioverter-defibrillator.
    Mosteller RD; Lehmann MH; Thomas AC; Jackson K
    Am J Cardiol; 1991 Nov; 68(13):1340-5. PubMed ID: 1951123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of the automatic implantable cardioverter-defibrillator in prolonging survival in patients with severe underlying cardiac disease.
    Fogoros RN; Elson JJ; Bonnet CA; Fiedler SB; Burkholder JA
    J Am Coll Cardiol; 1990 Aug; 16(2):381-6. PubMed ID: 2373816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The automatic implantable cardioverter defibrillator as a therapeutic modality for recurrent ventricular tachycardia: a case study.
    Kuiper RA
    Prog Cardiovasc Nurs; 1990; 5(1):6-12. PubMed ID: 2367517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Automatic implantable cardioverter defibrillators and survival of patients with left ventricular dysfunction and malignant ventricular arrhythmias.
    Tchou PJ; Kadri N; Anderson J; Caceres JA; Jazayeri M; Akhtar M
    Ann Intern Med; 1988 Oct; 109(7):529-34. PubMed ID: 3262325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defibrillation testing in everyday medical practice during implantable cardioverter defibrillator implantation in France: analysis from the LEADER registry.
    Sadoul N; Defaye P; Mouton E; Bizeau O; Dupuis JM; Blangy H; Delarche N; Blanc JJ; Lazarus A;
    Arch Cardiovasc Dis; 2013 Nov; 106(11):562-9. PubMed ID: 24200925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of sudden cardiac death in cardiac sarcoidosis using the wearable cardioverter defibrillator.
    Skowasch D; Ringquist S; Nickenig G; Andrié R
    PLoS One; 2018; 13(3):e0194496. PubMed ID: 29566033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surgical decisions in the management of sudden cardiac death and malignant ventricular arrhythmias. Subendocardial resection, the automatic internal defibrillator, or both.
    Hargrove WC; Josephson ME; Marchlinski FE; Miller JM
    J Thorac Cardiovasc Surg; 1989 Jun; 97(6):923-8. PubMed ID: 2724998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical experience in seventy-seven patients with the automatic implantable cardioverter defibrillator.
    Manolis AS; Tan-DeGuzman W; Lee MA; Rastegar H; Haffajee CI; Huang SK; Estes NA
    Am Heart J; 1989 Sep; 118(3):445-50. PubMed ID: 2773768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dofetilide reduces the frequency of ventricular arrhythmias and implantable cardioverter defibrillator therapies.
    Baquero GA; Banchs JE; Depalma S; Young SK; Penny-Peterson ED; Samii SM; Wolbrette DL; Naccarelli GV; Gonzalez MD
    J Cardiovasc Electrophysiol; 2012 Mar; 23(3):296-301. PubMed ID: 21955243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence and electrophysiological characteristics of spontaneous ventricular tachyarrhythmias in high risk coronary patients and prophylactic implantation of a defibrillator.
    Wolpert C; Kuschyk J; Aramin N; Spehl S; Streitner F; Süselbeck T; Schumacher B; Haase KK; Schimpf R; Borggrefe M
    Heart; 2004 Jun; 90(6):667-71. PubMed ID: 15145875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of electrophysiologic testing of the automatic implantable cardioverter-defibrillator on left ventricular systolic function and diastolic filling.
    Stoddard MF; Redd RR; Buckingham TA; McBride LR; Labovitz AJ
    Am Heart J; 1991 Sep; 122(3 Pt 1):714-9. PubMed ID: 1877447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Canadian hospital's experience with the automatic implantable cardioverter/defibrillator.
    Sharma AD; Guiraudon G; Klein GJ; Yee R
    CMAJ; 1987 Nov; 137(9):809-15. PubMed ID: 3442769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circadian variation of ventricular arrhythmia recurrences after cardioverter-defibrillator implantation in patients with healed myocardial infarcts.
    Mallavarapu C; Pancholy S; Schwartzman D; Callans DJ; Heo J; Gottlieb CD; Marchlinski FE
    Am J Cardiol; 1995 Jun; 75(16):1140-4. PubMed ID: 7762501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemodynamic changes due to intraoperative testing of the automatic implantable cardioverter defibrillator: implications for anesthesia management.
    Keyl C; Tassani P; Kemkes B; Markewitz A; Hoffman E; Steinbeck G
    J Cardiothorac Vasc Anesth; 1993 Aug; 7(4):442-7. PubMed ID: 8400100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Improved Left Ventricular Systolic Function on the Recurrence of Ventricular Arrhythmia in Heart Failure Patients With an Implantable Cardioverter-Defibrillator.
    Kim M; Kim J; Lee JH; Hwang YM; Kim MS; Nam GB; Choi KJ; Kim JJ; Kim YH
    J Cardiovasc Electrophysiol; 2016 Oct; 27(10):1191-1198. PubMed ID: 27334231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.